Abstract:Brain tumor segmentation is an important technique in computer-assisted diagnosis. To improve brain tumor diagnosis, it is necessary to use biochemical information provided by magnetic resonance spectroscopy (MRS). Some of the challenges involved are determining how to combine multimodal signals such as proton MRS and morphological or structural images, then knowing how to use the combined information to make a decision. In this paper, we propose using a data fusion method to perform an automatic segmentation of the brain tumor areas. To diagnose brain tissue abnormalities such as tumors, we need to use multispectral magnetic resonance images (MRIs), e.g. T1-weighted, T2-weighted, gadolinium, or FLAIR to determine some properties of the tumor, including size, position, sort, and relationship with other tissues. However, the tumor type and grade are usually diagnosed from histopathological examination of a surgical specimen. Proton (1H) magnetic resonance spectroscopy (MRS) is a non invasive MR technique that provides biochemical information about metabolites. The major biochemical characteristics can provide useful information about brain tumor type and grade (Howe et al., 2003a; 2003b). In many studies, the use of in vivo 1H-MRS has been described for determining tumor type and grade (Howe et al., 2003a; Howe et al., 2003b; Preul et al., 1996; Majos et al., 2009). Since analysis of in vivo MRS measurements are dependent on acquisition techniques that could compromise the spatial resolution and accuracy of resulting metabolite values (Maudsley et al., 2009), metabolic changes associated with disease are frequently small and diffuse. Furthermore, using the chemical-shift imaging (CSI) technique, metabolite images, known as MR spectroscopic imaging (MRSI) images, can be created using multivoxel MRS information, but it is not as visually interpretable as in a structural MRI (Maudsley et al., 2009). So, for tumor tissue classification, it is important that MRSI be combined with MRI to make a more accurate estimation of variations in metabolites, support hypotheses of metabolite variation causes, and to yield sufficient information about the tissue. For over a decade, scientists have been developing automated brain-tumor classification methods using MRS (Garcia-Gomez et al., 2009), but a more clear definition of brain tumor type and grade may be obtained by combining MRS or MRSI and MRI (Garcia-Gomez et al., 2009). A technique used to differentiate glioblastoma from metastatic lesions using MRI and

[Quantitative assessment of the usefulness of MR-fusion Tl-SPECT image in the diagnosis of brain tumor]

A Meta-Analysis on the Diagnostic Performance of (18)F-FDG and (11)C-Methionine PET for Differentiating Brain Tumors.

Fusion of MRI and DTI to Assist the Treatment Solution of Brain Tumor

Glial Tumors: Quantification and Segmentation from MRI and MRS

Comparison of Diagnostic Accuracy of Magnetic Resonance Spectroscopy with Conventional Magnetic Resonance Imaging for Brain Tumors and Correlation with Histopathology as Gold Standard

The Total Resection Rate of Glioma Can Be Improved by the Application of US-MRI Fusion Combined with Contrast-Enhanced Ultrasound

An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using 18F-FDG-PET and 11C-methionine PET

Combination of Magnetic Resonance Spectroscopy and 11C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma

Noninvasive Delineation of Glioma Infiltration with Combined 7T Chemical Exchange Saturation Transfer Imaging and MR Spectroscopy: A Diagnostic Accuracy Study

Evaluating the Diagnostic Efficacy of 99mTc-Methionine Single-Photon Emission Computed Tomography–Computed Tomography: A Head-to-Head Comparison with 11C-Methionine Positron Emission Tomography–Magnetic Resonance Imaging in Glioma Patients

Combination of Proton MR Spectroscopy and Diffusion-Weighted (DW) Imaging in the Evaluation of Common Intracranial Tumors

Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy

Relationship between multi-pool model-based chemical exchange saturation transfer imaging, intravoxel incoherent motion MRI, and 11C-methionine uptake on PET/CT in patients with gliomas

PET/MR fusion texture analysis for the clinical outcome prediction in soft-tissue sarcoma

1H-MR spectroscopy in grading of cerebral glioma: A new view point, MRS image quality assessment

Brain Tumor Segmentation through Data Fusion of T2-Weighted Image and MR Spectroscopy

Study of the Correlation between Magnetic Resonance Perfusion Imaging with IVIM and Dynamic Susceptibility Contrast Method in Brain Tumors

Magnetic Resonance Spectroscopic and Perfusion MRI in High Grade Gliomas and Metastases

A Combination of Amide Proton Transfer, Tumor Blood Flow, and Apparent Diffusion Coefficient Histogram Analysis Is Useful for Differentiating Malignant from Benign Intracranial Tumors in Young Patients: A Preliminary Study

Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI)

Study of Quantitative Diagnosis for Prostate Cancer-Combined MR Spectroscopy and Diffusion Weighted Imaging